No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Why Guardant Health, Inc. (GH) Soared At The Start Of The Trading Week
Guardant Health Analyst Ratings
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
Guardant Health (GH) Receives a Buy From Craig-Hallum
A Quick Look at Today's Ratings for Guardant Health(GH.US), With a Forecast Between $39 to $55
Guardant Health Up Over 22%, on Pace for Largest Percent Increase Since March 2019 -- Data Talk